The frequencies of CD38+CD43+ cells among CD19+ B cells were significantly elevated in active SLE than healthy controls (Figure 1B) and significantly reduced after intensification of the immunosuppressive therapy for active SLE and correlated with SLEDAI scores (Supplementary Figure 1). This evidence concerns the gene CD38 and systemic lupus erythematosus.